Stock listing
Candel Therapeutics, Inc.
Selected listing: CADL · NASDAQ · USD · US
Candel Therapeutics, Inc. (NASDAQ:CADL), Health Technology. Latest release Oct 2, 2026: Candel Therapeutics to Present at the SITC 2026 Annual Meeting.
- Ticker
- NASDAQ:CADL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Candel Therapeutics, Inc.
The company focuses on developing innovative therapies for cancer treatment. Candel is committed to advancing its pipeline of therapeutics to improve patient outcomes.
Latest news from Candel Therapeutics, Inc.
Candel Therapeutics to Present at the SITC 2026 Annual Meeting
October 2, 2026
Candel Therapeutics to Present at the SITC 2026 Annual Meeting
October 1, 2026
Candel Therapeutics Announces Publication of Phase 2a Trial Data that Demonstrated Prolonged Survival after Systemic Immune Reactivation by Aglatimagene Besadenovec plus Valacyclovir in Patients with Unresectable Stage III/IV NSCLC with an Inadequate Response to ICI
October 1, 2026
Candel Therapeutics Announces Publication of Phase 2a Trial Data that Demonstrated Prolonged Survival after Systemic Immune Reactivation by Aglatimagene Besadenovec plus Valacyclovir in Patients with Unresectable Stage III/IV NSCLC with an Inadequate ...
September 30, 2026
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026
Research Candel Therapeutics, Inc.
Candel Therapeutics, Inc. company profile
View the public company page for Candel Therapeutics, Inc. on 6ix.
Candel Therapeutics, Inc. news
Read company news and market updates connected to Candel Therapeutics, Inc..
Candel Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Candel Therapeutics, Inc..